117 related articles for article (PubMed ID: 38387818)
1. Doxorubicin loaded octacalcium phosphate particles as controlled release drug delivery systems: Physico-chemical characterization, in vitro drug release and evaluation of cell death pathway.
Kovrlija I; Pańczyszyn E; Demir O; Laizane M; Corazzari M; Locs J; Loca D
Int J Pharm; 2024 Mar; 653():123932. PubMed ID: 38387818
[TBL] [Abstract][Full Text] [Related]
2. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
Haque ST; Islam RA; Gan SH; Chowdhury EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
[No Abstract] [Full Text] [Related]
3. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
[TBL] [Abstract][Full Text] [Related]
4. Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle.
Fang Z; Sun Y; Xiao H; Li P; Liu M; Ding F; Kan W; Miao R
Biomed Pharmacother; 2017 Jan; 85():160-168. PubMed ID: 27930982
[TBL] [Abstract][Full Text] [Related]
5. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
Xu W; Lou Y; Chen W; Kang Y
Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
[TBL] [Abstract][Full Text] [Related]
6. In vitro delivery and controlled release of Doxorubicin for targeting osteosarcoma bone cancer.
Kamba SA; Ismail M; Hussein-Al-Ali SH; Ibrahim TA; Zakaria ZA
Molecules; 2013 Aug; 18(9):10580-98. PubMed ID: 23999729
[TBL] [Abstract][Full Text] [Related]
7. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
Li WM; Su CW; Chen YW; Chen SY
Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
[TBL] [Abstract][Full Text] [Related]
8. Toward a doxorubicin-loaded bioinspired bone cement for the localized treatment of osteosarcoma.
Martinez T; Sarda S; Dupret-Bories A; Charvillat C; Projetti F; Drouet C
Future Oncol; 2021 Sep; 17(26):3511-3528. PubMed ID: 34213375
[No Abstract] [Full Text] [Related]
9. Acid-Liable Cleavage of Doxorubicin@Plunoric-Carbon Dots in Multiplexed Bioimaging and Drug Delivery.
Priyadarshini E; Rajamani P
AAPS PharmSciTech; 2020 Nov; 21(8):322. PubMed ID: 33200276
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Formation Kinetics of Octacalcium Phosphate from Alpha-Tricalcium Phosphate: Synthesis Scale-Up, Determination of Transient Phases, Their Morphology and Biocompatibility.
Kovrlija I; Menshikh K; Marsan O; Rey C; Combes C; Locs J; Loca D
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979398
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor.
Zhang J; Zhang H; Jiang J; Cui N; Xue X; Wang T; Wang X; He Y; Wang D
Int J Nanomedicine; 2020; 15():433-444. PubMed ID: 32021189
[TBL] [Abstract][Full Text] [Related]
12. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.
Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z
Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003
[TBL] [Abstract][Full Text] [Related]
13. Polymeric Composite Matrix with High Biobased Content as Pharmaceutically Relevant Molecular Encapsulation and Release Platform.
Hazra RS; Dutta D; Mamnoon B; Nair G; Knight A; Mallik S; Ganai S; Reindl K; Jiang L; Quadir M
ACS Appl Mater Interfaces; 2021 Sep; 13(34):40229-40248. PubMed ID: 34423963
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
Li Y; Hou H; Zhang P; Zhang Z
Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
[TBL] [Abstract][Full Text] [Related]
16. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
Rathore K; Cekanova M
Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
[TBL] [Abstract][Full Text] [Related]
17. Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.
Nittayacharn P; Nasongkla N
J Mater Sci Mater Med; 2017 Jul; 28(7):101. PubMed ID: 28534285
[TBL] [Abstract][Full Text] [Related]
18. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
Qiu R; Sun D; Bai Y; Li J; Wang L
Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
[TBL] [Abstract][Full Text] [Related]
19. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
Prasad SR; Jayakrishnan A; Kumar TSS
J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
[TBL] [Abstract][Full Text] [Related]
20. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
